Major Industry Changes Affecting Pharmaceutical Companies 🇪🇺 EU Pharma Package Reform 2025

The European Commission is reshaping market-exclusivity periods, supply-chain duties, and orphan-drug incentives through the upcoming “Pharma Package.”

What This Means for You:

  • Reassess EU launch and submission timelines.
  • Prepare for stricter availability and shortage-reporting rules.
  • Update eTMF and PV systems to capture new regulatory obligations.

Leave a Reply

Your email address will not be published. Required fields are marked *